Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anne-Laure Sandenon Seteyen"'
Autor:
Anne-Laure Sandenon Seteyen, Pascale Guiraud, Philippe Gasque, Emmanuelle Girard-Valenciennes, Jimmy Sélambarom
Publikováno v:
Pharmaceuticals, Vol 16, Iss 8, p 1125 (2023)
O’nyong-nyong virus (ONNV) is a member of the reemerging arthritogenic alphaviruses that cause chronic debilitating polyarthralgia and/or polyarthritis via their tropism for the musculoskeletal system. Thus, the discovery of dual antiviral and anti
Externí odkaz:
https://doaj.org/article/b8f21bebd0234df794234443496d93df
Autor:
Axelle Septembre-Malaterre, Ahcène Boumendjel, Anne-Laure Sandenon Seteyen, Chailas Boina, Philippe Gasque, Pascale Guiraud, Jimmy Sélambarom
Publikováno v:
Phytomedicine Plus, Vol 2, Iss 1, Pp 100220- (2022)
Background: Polyphenols and particularly flavonoids are of constant interest to the scientific community. Flavonoids are investigated for their biological and pharmacological purposes, notably as antioxidant, anticancer, antiviral and for their anti-
Externí odkaz:
https://doaj.org/article/c143a18b16f9445188d66ce87585bc7b
Autor:
Anne-Laure Sandenon Seteyen, Emmanuelle Girard-Valenciennes, Axelle Septembre-Malaterre, Philippe Gasque, Pascale Guiraud, Jimmy Sélambarom
Publikováno v:
Molecules, Vol 27, Iss 16, p 5080 (2022)
The discovery and the development of safe and efficient therapeutics against arthritogenic alphaviruses (e.g., chikungunya virus) remain a continuous challenge. Alkaloids are structurally diverse and naturally occurring compounds in plants, with a wi
Externí odkaz:
https://doaj.org/article/86f57098ba884317a41e87337340eb61
Autor:
Anthony Dobi, Arthur Dubernet, Mahary Lalarizo Rakoto, Anne-Laure Sandenon Seteyen, Damien Vagner, Grégorie Lebeau, Loïc Raffray, Philippe Gasque
Publikováno v:
Immunologic Research. 70:714-719
Autor:
Anne-Laure Sandenon Seteyen, Loic Raffray, Axelle Septembre-Malaterre, Philippe Gasque, Grégorie Lebeau, Claude Giry, Mahary Lalarizo Rakoto, Etienne Frumence, Wildriss Viranaicken, Damien Vagner, Anthony Dobi
Publikováno v:
Journal of Immunological Methods
Journal of Immunological Methods, 2021, 495, pp.113082. ⟨10.1016/j.jim.2021.113082⟩
Journal of Immunological Methods, Elsevier, 2021, 495, pp.113082. ⟨10.1016/j.jim.2021.113082⟩
Journal of Immunological Methods, 2021, 495, pp.113082. ⟨10.1016/j.jim.2021.113082⟩
Journal of Immunological Methods, Elsevier, 2021, 495, pp.113082. ⟨10.1016/j.jim.2021.113082⟩
International audience; The development of new diagnostic assays become a priority for managing COVID-19. To this aim, we presented here an in-house ELISA based on the production of two major recombinant and high-quality antigens from SARSCoV-2. Full
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e532414fd9823cbf739a868585e6237c
https://hal.univ-reunion.fr/hal-03321861
https://hal.univ-reunion.fr/hal-03321861
Autor:
Anne-Laure Sandenon Seteyen, Loic Raffray, Mahary Lalarizo Rakoto, Grégorie Lebeau, Etienne Frumence, Damien Vagner, Anthony Dobi, Claude Giry, Philippe Gasque, Axelle Septembre-Malaterre, Marie-Christine Jaffar-Bandjee
Both cellular and humoral immunities are critically important to control COVID19 infection but little is known about the kinetics of those responses and, in particular, in patients who will go on to develop a severe form of the disease over several w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1d42dac588cc759051d8de544a8c85ee